Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Merck & Company Inc (MRK)

NYSE
Currency in USD
Disclaimer
125.78
+0.55(+0.44%)
Closed
After Hours
125.61-0.17(-0.14%)

MRK Comments

This will be 120+ soon
why Mr. Zingone at 120+ soon ? any reason please ? if you can help me i will appreciate so much . Best Regards, Elon.
As soon as they start selling their covid drug in USA
only up 21% since you referred to me as a mron
ma e' sui massimi da sempre? che t.p. si puo' immaginare a questo punto ?
🚀🚀🚀🚀🚀🚀🚀🌜
Good, even great reasults in first quater of 2022.Let's hope to go back to 86-87 territory
The invention relates to stable formulations of antibodies against human programmed death receptor PD-1, or antigen binding fragments thereof and a PH20 variant or fragment thereof. The invention further provides methods for treating various cancers with formulations of the invention.
The invention relates to stable formulations of antibodies against human programmed death receptor PD-1, or antigen binding fragments thereof and a PH20 variant or fragment thereof. The invention further provides methods for treating various cancers with formulations of the invention. In some embodiments of the methods of the invention, the formulations are administered to a subject by subcutaneous administration.
The invention relates to stable formulations of antibodies against human programmed death receptor PD-1, or antigen binding fragments thereof and a PH20 variant or fragment thereof. The invention further provides methods for treating various cancers with formulations of the invention. In some embodiments of the methods of the invention, the formulations are administered to a subject by subcutaneous administration.
It was 22 in 1995. Do the math and look at the products.
Hope can break 80 this week
It should reach 120 soon
Above 80 in near future. Many good things happeni.
good and important rebound today.Everything above 77 will show that iwill go up later this week and month.
Remember those buy the covid pill jokers, wiped? or did they bail out? as still it is trading in channel
Earnings are good, why it is going down?
Yeah what he said
we should eat some peanuts
hello! Price after earning from tomorrow?
Results are good, but not mind blowing.I assume we will not see big changes in price.
4% ?
No)))The problem is with 2022 guidence. Company hopes to earn less than analyst thought. I think we will be lucky to stay at 78-82 Level.
It’s been moving up slowly but surely, that’s good enough given the current market situation
is it worth to entry now in Merck ?
merck got treatment approved with great fundamentals and undervalued pricing below 100 per share. id say now's around the time to buy before the rallies.
today 12/27 is working New York Exchange and European Exchanges do you know that please ?
has been quit here lol the buyers bought air. told u. chart = defensive = channel. = simple, basic investing knowledge
this price is a God gift. Buy 100 share now. 72.62
dropping ?
MRk is oversold. Support of 72$ should hold imo.
i bought mrk, i'm watching when to entry
Bought 240 shares today for 72,30$ long
I think this is a good time to pick up some more of this! It can only get better!
Buy! Buy! Buy! This is only going up!
aah a drop to the second line is a second buy place then just under 72$
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.